Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
4.
J Med Microbiol ; 47(1): 85-90, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9449954

ABSTRACT

Nocardia asteroides has long been recognised as a heterogeneous group of organisms. The description and identification of two new subgroups, N. farcinica and N. nova, in other countries encouraged us to re-examine a collection of N. asteroides isolates from the UK. Of 73 clinical isolates identified as N. asteroides from different parts of England and Wales during 1991-1993, and now subjected to further differentiation tests by the Mycobacterial/Nocardial Reference Laboratory, 15 (20.5%) were identified as N. farcinica based on three out of four characteristics: growth property, acetamide production, rhamnose assimilation and a distinct antibiogram. No isolates were identified as N. nova. A revised identification and susceptibility system has significant clinical and taxonomic implications. Its introduction will improve speciation, identify antibiotic resistance and influence the choice of safer alternative therapy for patients infected with Nocardia spp. in the UK.


Subject(s)
Nocardia Infections/microbiology , Nocardia/classification , Bacterial Typing Techniques , Cluster Analysis , Drug Resistance, Microbial , Humans , Microbial Sensitivity Tests , Nocardia/drug effects , Nocardia/isolation & purification , United Kingdom
5.
Eur J Clin Microbiol Infect Dis ; 16(10): 743-6, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9405945

ABSTRACT

In a study to determine the prevalence of urinary tract infections (UTI) in primary biliary cirrhosis, midstream specimens of urine from 97 females with primary biliary cirrhosis and 85 females with other chronic liver diseases were investigated prospectively for urinary pathogens and Mycobacterium gordonae. No significant differences between primary biliary cirrhosis and the two groups were observed in the prevalence of significant bacteriuria (11.3% vs. 7.1%), the prevalence of Escherichia coli UTI (9.3% vs. 7.1%) or the colony morphology of Escherichia coli. No mycobacterial species were grown from any sample. In both groups, the prevalence of UTI was higher in patients with cirrhosis (20% in both) than in those without.


Subject(s)
Liver Cirrhosis, Biliary/complications , Liver Diseases/complications , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiology , Adult , Aged , Chronic Disease , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/epidemiology , Escherichia coli Infections/diagnosis , Escherichia coli Infections/epidemiology , Female , Humans , Klebsiella Infections/diagnosis , Klebsiella Infections/epidemiology , Middle Aged , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/epidemiology , Prevalence , Prospective Studies , Streptococcal Infections/diagnosis , Streptococcal Infections/epidemiology , Urinary Tract Infections/diagnosis
6.
J Hosp Infect ; 35(3): 169-74, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9093915

ABSTRACT

Recent technological advances have led to the development of several types of invasive procedures in the fetus principally for the diagnosis and management of fetal disorders. The risk of infection to the fetus related to these procedures needs evaluation. Although there are few reports of fetal infection, proper infection control procedures must be observed because the most common consequence of infection is fetal loss. Fetal blood sampling in the presence of chorioamnionitis is a risk factor that warrants prophylactic antibiotics. Conversely, clinical specimens taken from the fetus in the absence of chorioamnionitis are more likely to become contaminated with maternal skin flora, and a positive fetal blood culture is not necessarily significant. There is probably a small but finite risk of transmission of maternal viral infections such as human immunodeficiency virus, hepatitis B and C, cytomegalovirus and herpes simplex during invasive procedures. Obstetric departments undertaking invasive fetal diagnosis and treatment must have an adequate policy for infection control procedures.


Subject(s)
Bacterial Infections/etiology , Cross Infection/etiology , Fetal Diseases/etiology , Prenatal Diagnosis/adverse effects , Virus Diseases/etiology , Bacterial Infections/prevention & control , Cross Infection/prevention & control , Fetal Diseases/prevention & control , Humans , Infection Control/methods , Risk Factors , Virus Diseases/prevention & control
8.
J Infect ; 32(1): 27-32, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8852548

ABSTRACT

The treatment of salmonella osteomyelitis in sickle cell disease (SCD) is difficult and the emergence of antibiotic resistance in Salmonella spp presents further problems for clinicians treating SCD. Three patients presented with salmonella bacteraemia. Treatment with several intravenous antibiotics did not prevent the subsequent development of osteomyelitis. Emergence of resistance to multiple antibiotics, including ciprofloxacin, during the treatment of salmonella osteomyelitis in SCD patients is reported here for the first time. Ceftriaxone 2 g once daily given for 3 months to 3 years was an effective and convenient treatment for osteomyelitis caused by multiply-resistant salmonella. Two of these patients gave a definite history of diarrhoea, and stool cultures confirmed the presence of Salmonella spp in one. Our experience shows that salmonella osteomyelitis may not be prevented by early treatment of bacteraemia in SCD patients. Other measures to reduce the risk of salmonella infection are therefore necessary.


Subject(s)
Anemia, Sickle Cell/complications , Anti-Infective Agents/therapeutic use , Ciprofloxacin/therapeutic use , Osteomyelitis/drug therapy , Salmonella Infections/drug therapy , Salmonella/drug effects , Adult , Drug Resistance, Microbial , Female , Humans , Male , Osteomyelitis/etiology , Salmonella Infections/etiology
9.
Commun Dis Rep CDR Rev ; 5(4): R54-6, 1995 Mar 31.
Article in English | MEDLINE | ID: mdl-7735351

ABSTRACT

In microbiology laboratories highly infectious material is handled alongside complex and potentially dangerous equipment, and staff are therefore at risk of infections and accidents. Acts of parliament and regulations exist to protect staff in the workplace, including those exposed to biological agents. The current monitoring of health and safety in laboratories seeks to ensure that employers and employees comply with existing regulations, but this form of passive surveillance is of limited value because it does not highlight shortcomings in techniques, equipment, premises, or personnel. We propose a scheme for the surveillance of health and safety in microbiology laboratories that will actively seek information about laboratory incidents and practices, in order to enable appropriate preventive measures to be instituted.


Subject(s)
Accidents, Occupational/statistics & numerical data , Laboratory Infection/epidemiology , Microbiological Techniques , Population Surveillance , Accidents, Occupational/prevention & control , Humans , Laboratory Infection/prevention & control , Risk Management
10.
J Hosp Infect ; 27(3): 195-9, 1994 Jul.
Article in English | MEDLINE | ID: mdl-7963460

ABSTRACT

A review of all blood culture isolates for the 16 years from 1976 were collated with prospective laboratory and clinical records of 620 sickle cell patients treated at King's College Hospital. Over half of all salmonella bacteraemias diagnosed in the clinical laboratory occurred in sickle cell disease (SCD) patients. Of 21 bacteraemias in SCD patients, 11 (52.3%) were due to Salmonella spp. compared with 23 (0.4%) of 4884 bacteraemias in patients without SCD (P = < 0.00001). In SCD, Gram-negative bacilli were responsible for 16 (76.2%) bacteraemias, of which 11 (68.8%) were due to Salmonella spp. but there were no cases of S. typhi or S. paratyphi. An increase in the number of salmonella infections over the past 5 years were noted in the SCD and non-SCD patients, nine and 16 cases respectively, compared with two and seven cases in the previous decade. However, the recent increase of S. enteritidis phage type 4 in the UK was not evident in SCD patients. These findings have important preventative and therapeutic implications for the management of SCD patients.


Subject(s)
Anemia, Sickle Cell/complications , Bacteremia/complications , Salmonella Infections/complications , Bacteremia/epidemiology , Bacteremia/microbiology , Hospitals, University , Humans , London/epidemiology , Prospective Studies , Salmonella Infections/epidemiology , Salmonella Infections/microbiology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...